AstraZeneca teams up with Oxford University to develop COVID-19 vaccine

(Reuters) - Britain's AstraZeneca joined forces with the University of Oxford on Thursday to help develop, produce and distribute a potential COVID-19 vaccine, as drugmakers around the world race to find a solution to the deadly disease.UK Business Secretary Alok Sharma welcomed the tie-up as a vital step to making the Oxford vaccine available as soon as possible if it succeeds in clinical trials. A team of British scientists last week dosed the first volunteers, and earlier this month said..